CD8A and COVID-19: Studies in adult populations that have included convalescent time points demonstrate that about 70%–90% of adults with COVID-19 have detectable CD4+ and CD8+ T cell responses 1 month after symptom onset (17), which is remarkably similar to what we found in children.